Med-IQ Logo
Get CME/CE

Earn CME

Implementing PrEP in Clinical Practice: Assessing HIV Risk and Supporting PrEP Adherence to Maximize HIV Prevention
Webcast Webcast

Implementing PrEP in Clinical Practice: Assessing HIV Risk and Supporting PrEP Adherence to Maximize HIV Prevention


Time to Complete:
1 hour
Released:
10/7/16
Expires:
10/6/17
PDF:

Maximum Credits:

1.0 AMA PRA Category 1 Credit(s)
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Webcast Webcast
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.
Time to Complete:
1 hour

Released:
10/7/16

Expires:
10/6/17

PDF:

Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)
Share on:
Webcast Webcast
By clicking "Start," you are confirming that you have reviewed the CME information and read, understood, and unconditionally agreed to the Privacy Policy and Terms of Service.

Share on:


Time to Complete:
1 hour
Released:
10/7/16
Expires:
10/6/17
PDF:


Maximum Credits:
1.0 AMA PRA Category 1 Credit(s)


Overview: In this conversation-style Webcast, leading experts in the fields of human immunodeficiency virus (HIV) prevention and pre-exposure prophylaxis (PrEP) discuss features of a sexual history that identify patients at risk of HIV transmission as PrEP candidates, approaches for implementing the PrEP cascade in clinical practice for patients at high risk of HIV, and the impact of adherence and nondaily dosing on PrEP effectiveness. Additionally, the panel discusses adherence-related challenges that patients taking PrEP may encounter and offers tools to maximize the effectiveness of PrEP as an HIV-prevention strategy.

Faculty

Richard Elion, MD

Associate Professor of Clinical Medicine

George Washington University School of Medicine

Washington, DC

Robert M. Grant, MD, MPH

Betty Jean and Hiro Ogawa Endowed Investigator

Gladstone Institute of Virology and Immunology

Professor of Medicine

University of California, San Francisco

Chief Medical Officer, San Francisco AIDS Foundation

San Francisco, CA

Dázon Dixon Diallo, DHL, MPH

President & CEO

SisterLove, Inc.

Atlanta, GA


Disclosure Policy

Med-IQ requires any person in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines “relevant financial relationships” as those in any amount occurring within the past 12 months, including those of a spouse/life partner, that could create a conflict of interest (COI). Individuals who refuse to disclose will not be permitted to contribute to this CME activity in any way. Med-IQ has policies in place that will identify and resolve COIs prior to this educational activity. Med-IQ also requires faculty to disclose discussions of investigational products or unlabeled/unapproved uses of drugs or devices regulated by the US Food and Drug Administration.


Disclosure Statement

The content of this activity has been peer reviewed and has been approved for compliance. The faculty and contributors have indicated the following financial relationships, which have been resolved through an established COI resolution process, and have stated that these reported relationships will not have any impact on their ability to give an unbiased presentation.  

Richard Elion, MD
Consulting fees/advisory boards: Gilead Sciences, Inc., Merck & Co., Inc., ViiV Healthcare
Fees received for promotional/non-CME activities: Gilead Sciences, Inc., Janssen Pharmaceuticals, Inc., Merck & Co., Inc., ViiV Healthcare
Other (expert witness): Gilead Sciences, Inc.
 
Robert M. Grant, MD, MPH, has indicated no real or apparent conflicts.

Dázon Dixon Diallo, DHL, MPH
Consulting fees/advisory boards: Gilead Sciences, Inc., Merck & Co., Inc., ViiV Healthcare
Fees received for promotional/non-CME activities: Merck & Co., Inc.

The peer reviewers and activity planners have no financial relationships to disclose.

This activity has been approved for AMA PRA Category 1 Credit™.


This activity is supported by an educational grant from Gilead Sciences, Inc.

Unless otherwise indicated, photographed subjects who appear within the content of this activity or on artwork associated with this activity are models; they are not actual patients or doctors.

Share With Patients

Patient PrepPoints Share this education by visiting Patient PrepPoints, where patients can learn more about protecting themselves against HIV.

VIEW TODAY

Note: This material is not CME certified and, therefore, does not offer any CME/CE credit.

Play Video
The trifecta of healthcare improvement: value-based care, quality improvement, and technology.

See how Med-IQ is helping to enhance patient outcomes in these short videos.

Scott Weber, CEO Med-IQ

From Volume to Value-Based Care: The Role of the CME Enterprise

Scott Weber, CEO,
Med-IQ

Allison Gardner, PhD, VP Educational Strategy and Content, Med-IQ

The Value of Quality Improvement and Education to Advance Healthcare

Allison Gardner, PhD,
VP Educational Strategy and Content,
Med-IQ

Dr. Glenn Treisman,
Department of Psychiatry, Johns Hopkins Medical Institute

The Pros and Cons of Technology on the Practice of Medicine

Dr. Glenn Treisman,
Department of Psychiatry,
Johns Hopkins Medical Institute


Need help? If you need to speak with a member of our team, please call (toll-free) 866 858 7434 or e-mail info@med-iq.com. For technical assistance, please refer to our support manual.